IL22 and COVID-19: Given the central role of Th17 immunity in the pathogenesis of psoriasis, the therapeutic efficacy of targeted IL-17 blockade,10 and the association between Th17 cell activation and severe COVID-19,15, 16 we next analysed IL-17A and IL-22 cytokine responses to total spike peptide pools across the study groups.